LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy
Article in Frontiers in Immunology (January 2023)
The most recent citing publications are shown below. View all 52 publications that cite this research output on Dimensions.
Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis
Article in Journal of Hypertension (July 2022)
Research progress on epigenetics of small B-cell lymphoma
Article in Clinical and Translational Oncology (March 2022)